GMO Gaika Gaika ex trading value falls to ¥34.7126 trillion in October 2026

GMO Gaika Gaika ex reported lower monthly OTC foreign-exchange trading value in October 2026, alongside a comparatively modest decline in its month-end account count. The preliminary disclosure from GMO Financial Holdings points to a sharper contraction in transaction activity than in the number of accounts recorded for this subsidiary and product.

October trading value was ¥34.7126 trillion, compared with ¥48.184 trillion in September. That is a substantial month-on-month reduction in the value traded, rather than a near-flat reading. The comparison establishes a weaker October relative to the immediately preceding month; two monthly observations do not establish whether the decline represents a persistent trend or a temporary change in activity.

The account measure moved less markedly. GMO reported 491,871 accounts at the end of October, against 492,574 at the end of September. This is a comparison between two month-end balances, not a count of customers who traded during either month. It therefore describes the recorded account base without showing how many accounts participated in the transactions behind the monthly trading total.

Read together, the measures support a narrow but useful operating judgment: trading activity weakened considerably while the recorded account base changed only slightly. The account decline alone should not be treated as an explanation for the trading decline. A relatively stable account balance can coexist with substantial changes in trading, because the balance does not reveal participation or the distribution of transaction values across accounts. The disclosure does not identify which of those dimensions changed in October.

This distinction also keeps the commercial interpretation proportionate. The reported movement concerns transaction value, not earnings, and it should not be presented as a measured deterioration in profitability. Nor does a lower aggregate trading total establish that individual customers traded less or experienced a particular financial outcome. Those conclusions would go beyond what these two operating measures show.

The figures apply specifically to GMO Gaika Gaika ex, not to GMO CLICK Securities FX Neo or the wider retail FX industry. They are preliminary company self-disclosures and may be revised by GMO. For this reporting scope, the clearest October signal remains the divergence in scale between the trading contraction and the much smaller movement in recorded accounts.